VivioMD scores 57/100 (grade C, ranked #406) on The Verdict Score. Here are the top-rated GLP-1 providers we'd weigh against it — same six-factor rubric, and no score is adjusted for payment.
VivioMD — FDA warning letter, June 2026. Addressed to VivioMD Group LLC dba VivioMD, and public in FDA’s warning-letter database.
Rixa Health is a direct-to-consumer functional-medicine telehealth practice prescribing compounded and oral semaglutide and tirzepatide (plus other peptides) for weight loss via partner US pharmacies.
Rixa Health matches VivioMD at 57/100; the full Rixa Health review has the pricing conditions and the caveats in detail.
Metabolyz is a nationwide GLP-1 telehealth platform offering three compounded programs — standard semaglutide, dual-agonist tirzepatide, and a microdose protocol for patients near goal weight or intolerant…
Metabolyz matches VivioMD at 57/100; the full Metabolyz review has the pricing conditions and the caveats in detail.
Washington DC telehealth platform with month-to-month compounded GLP-1 plans, undermined by a pricing page that contradicts itself on whether consultations cost extra.
KERNX Health scores 56/100 to VivioMD's 57; the full KERNX Health review has the pricing conditions and the caveats in detail.
LifespanningRx is a clinician-guided longevity and peptide telehealth brand whose Weight Loss Program prescribes compounded GLP-1 (semaglutide/tirzepatide) injectables alongside peptide and healthy-aging…
1st Optimal is a Michigan-based telehealth and functional-medicine platform offering GLP-1 weight loss medications, including semaglutide and tirzepatide, as once-weekly injections or daily oral tablets.
1st Optimal scores 56/100 to VivioMD's 57; our 1st Optimal ruling in full has the pricing conditions and the caveats in detail.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.